Clinical Trial Update: IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

View source ↗

Summary

This clinical trial update indicates that intravenous immunoglobulin (IVIG) is being studied for drug- and device-refractory gastrointestinal autoimmune neuropa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Motility Disorders
• Gastroparesis
• Peripheral Neuropathy

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of Louisville | Conditions: Gastrointestinal Motility Disorder, Gastroparesis | Status: RECRUITING